Zurich/Basel – Evoleen, the Zurich-based incubator for innovative start-ups in the digital healthcare sector, is investing in docjo as a co-founder. Marcel Wüthrich from Evoleen joins the Board of Directors of the start-up company. It offers digital solutions for several of the most common chronic diseases.
Evoleen is a new co-founder of docjo. This has now been announced by the spin-off of the internationally award-winning Swiss-Israeli digital health platform provider docdok.health. Docjo is based at the Novartis Campus of the Switzerland Innovation Park Basel Area.
Marcel Wüthrich, CBDO and CCO of Evoleen, joins the docjo founding team as CBDO and takes a seat on the Board of Directors. In addition to Wüthrich, CEO Dr. Ulrich Mühlner and CMO Dr. Yves Nordmann are among the founders. Mühlner is the initiator of docdok.health as well as its director and head of strategy. Nordmann is a Swiss-Israeli serial entrepreneur who has already founded three digital health companies: WellDoc in the USA, Oviva headquartered in Zurich and E-Medicus from Basel.
Docjo is a so-called software-as-medical-device company. It takes a platform and portfolio approach with a pipeline of digital solutions for several of the most common chronic diseases. Two apps from docjo are already CE-certified, one for prediabetes and one for asthma. According to the information provided, they are currently being prepared for market entry.
"We were looking for a co-shaper, technology and go-to-market partner," says docjo CEO Ulrich Mühlner, who is "used to working in a highly regulated environment while still being agile. With Evoleen, we have found all of this in a single company, which is very rare." ce/mm